Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Enhancement of Management of breast cancer in French speaking Sub-Saharan African Countries
    Release Date:
    Partner: AMFROM
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Benin, Congo, The Democratic Republic, Mali, Senegal, Togo
    Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize Management
    Release Date:
    Partner: Beijing Guangda Precision Medicine Research Center
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology China
    Optimizing Antimicrobial Stewardship Program in Saudi Arabia
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Saudi Arabia
    Invasive Mold Infections (IMI) - Real-World Evidence from Treatment Outcomes with Isavuconazole
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Australia, Germany, Israel, Italy, Spain, Switzerland
    PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Pediatric pneumococcal carriage and serotype distribution surveillance: prospective studies in South-East Asia, 2025-2026
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines India, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Advancing Health Care Professionals’ knowledge and understanding of adult and maternal vaccination against respiratory infection
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Ireland, Israel, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Slovenia, Ukraine
    Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of
    The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital China, Hong Kong
    COVID-19 Disease Burden on the High Risk Population
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
    New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel Disease
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Improving the Care of Persons Living with Metastatic Breast Cancer
    Release Date:
    Partner: Rethink Breast Cancer
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Addressing knowledge and practice gaps in changing paradigms of dermatological inflammatory conditions
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Inflammation & Immunology Canada
    Improving Advanced Prostate Cancer Management in Latin America
    Release Date:
    Partner: Prostate Cancer Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Chile, Colombia, Mexico
    Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient Care
    Release Date:
    Partner: The PROTEUS Consortium
    Review Process: Expert Review Panel
    Research Oncology USA
    Addressing Knowledge Gaps in Ulcerative Colitis (UC) Care
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2024 Inflammatory Bowel Disease (IBD) Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    Closing the HRRm Testing Gap in Prostate Cancer Patients
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Improving the care and outcomes of residents of Canada living with metastatic NSCLC
    Release Date:
    Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung Association
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Improving the Equity and Quality of Cancer Care in Colombia
    Release Date:
    Partner: The Colombian Association of Oncology and Hematology (ACHO)
    Review Process: Expert Review Panel
    Translation: Spanish (link)
    Quality Improvement Oncology Colombia
    Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
    Release Date:
    Partner: Colorectal Cancer Canada (CCC)
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    IBD QORUS HEALTH EQUITY REQUEST FOR APPLICATIONS (RFA)
    Release Date:
    Partner: Crohn's & Colitis Foundation
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology USA